Glenmark Pharmaceuticals Limited
532296
ISIN INE935A01035 / Valor 3195888
Glenmark Pharmaceuticals Limited
UMushroom community rating:
About company
Glenmark Pharmaceuticals Limited is an India‑headquartered multinational drug company that researches, develops, manufactures and markets prescription and over‑the‑counter medicines across multiple geographies. Its commercial business combines branded generics in India and other emerging markets with generic and specialty products sold in developed markets such as the United States and Europe; key therapeutic areas include respiratory, dermatology and oncology, and the company has pursued biosimilars and novel small molecules through its R&D pipeline. Glenmark operates manufacturing and research facilities domestically and abroad and distributes products via subsidiaries and partner networks, pairing ongoing regulatory filings and clinical development with the sale of marketed pharmaceuticals.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
6776 M
Market cap (USD)
29,832
Daily traded volume (Shares)
/
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
